Details
Hits: 2661

"Biotechnologia Acta" V. 9, No 6, 2016
https://doi.org/10.15407/biotech9.06.007
Р. 7-15, Bibliography 66, English
Universal Decimal Classification:  604.4:615.371

 6 2016

THE APPROACHES TO DESIGNING OF NEW GENERATION VACCINES AGAINST THE SHEEP POX DISEASE

E. F. Yilmaz 1, P. P. Arayici 1, A. M. Maharramov 2, Z. Mustafaeva 1

1 Yildiz Technical University, Istanbul, Turkey
2 Baku State University, Azerbaijan

In this review the authors analyzed the sheep pox disease, which occurs outbreaks all over the world particularly in Asia and Africa causing substantial losses in trade of animal and animal products. They categorized the sheep pox disease   is one of the prioritized groups of diseases against which the World Organization for Animal Health is fighting. Data concerning a sheep poxes’ history, epidemiology, epizootiology, mortality and economic impact, clinical and pathological signs, features of capripoxvirus that forms the disease are given.  Diagnosis treatment and vaccine have been investigated as well. The main conclusion is done according which the designing of new vaccine generation against the sheep pox disease   could be as an alternative approach against sheep pox.

Ключові слова: Sheep pox, synthetic peptide vaccines, Capripoxvirus, Polymeric adjuvant.

© Palladin Institute of Biochemistry of National Academy of Sciences of Ukraine, 2016

{accordion title="References" open="false"}

  1.  Babiuk S., Bowden T. R., Boyle D. B., Wallace D. B., Kitching R. P. Capripoxviruses: An Emerging Worldwide Threat to Sheep,Goats and Cattle. Transbound. Emerg. Dis. 2008, 55 (7), 263?272. https://doi.org/10.1111/j.1865-1682.2008.01043.x
  2. Hasoksuz M., Gulyaz V., Sarac F. Molecular Characterizations of Sheeppox Virus Strains. Transbound. Emerg. Dis. 2014, 55 (7), 63?72. https://doi.org/10.16988/iuvfd.81058
  3. Barut F. S???rlar?n Nod?ler Ekzantemi Lumpy Skin Disease (LSD) Hastal?k Kart?. Etlik Veteriner Kontrol Merkez Ara?t?rma Enstit?s? Virolojik Te?his Laboratuvar?, from http://docplayer.biz.tr/17564685-Sigirlarin-noduler-ekzantemi-lumpy-skin-disease-lsd-hastalik-karti-hazirlayan-dr-m-fatih-barut-vet-hekim.html (accessed, December 2016).
  4. Gulyaz V., Ozdemir S. Kombine Haz?rlanan Koyun ?i?ek Ve Koyun-Ke?i Vebas? A??s?n?n Ba????kl?k. Pendik Vet. Mikrobiyol. Derg. 2010. 37 (1), 3?9.
  5.  Sozdutmaz ?. Koyun?Ke?i ?i?e?i Hastal???n?n Polimeraz Zincir Reaksiyonu ile Tan?s?nda Farkl? Klinik ?rneklerin Kullan?m?. Atat?rk ?niversitesi Vet. Bil. Derg. 2010, 5 (3), 113?119.
  6. OIE, W.O.F.A.H., Manual of Diagnostic Tests and Vaccines for Terrestrial Animals Sheep pox and goat pox. Chapter 2. July 7, 2008, from www.oie.int/doc/ged/D7710.PDF.
  7. Varshovi H. R., Keyvanfar H., Aghaiypour K., Pourbakhsh S. A., Shooshtar A. H., Aghaebrahimian M. Capripoxvirus identification by PCR based on P32 gene. Arch. Razi Insti. 2009, 64 (1), 19?25.
  8. Bhanuprakash V., Indrani B. K., Hosamani M., Singh R. K. The current status of sheep pox disease. Comp. Immunol. Microbiol. Infect. Dis. 2006, V. 29, P. 27–60. https://doi.org/10.1016/j.cimid.2005.12.001
  9. Rao T. V. S., Bandyopadhyay S. K. A. Comprehensive review of goat pox and sheep pox and their diagnosis. Anim. Health Res. Rev. 2000, 1 (2), 127–136. https://doi.org/10.1017/S1466252300000116
  10. Sozdutmaz ?. Virological, serological and epizootiological investigations of sheep pox and goat pox diseases in northeast anatolian region (Doctoral dissertation). Available from https://tez.yok.gov.tr/UlusalTezMerkezi/. 2010. (No. 260529).
  11. Cam V. M. Control of capripoxvirus infections. Vaccine. 1993, 11 (13), 1275–1279. https://doi.org/10.1016/0264-410X(93)90094-E
  12. Yilmaz H., Turan N., Hasoksuz M. Viroloji Ders Notu. ?. ?. Veteriner Fak?ltesi Viroloji Anabilim Dal?. Available at http://veteriner.istanbul.edu.tr/wp-content/./V?ROLOJ?-DERS-notu-Kitab?-27.12.2013.pdf (accessed, December 2016)
  13. Parth?ban M., Gov?ndarajan R., Manoharan S., Purushothaman V., Chandran N. D. J., Koteeswaran A. Comparative sequence analysis of diagnostic PCR amplicons from Indian sheeppox virus. Vet. Arhiv. 2005, N 75, P. 203–209.
  14. Aldaiarov N., Stahel A., Nufer L., Jumakanova Z., Tulobaev A., Ruetten M. Outbreak of sheeppox in farmed sheep in Kyrgystan: Histological, eletron micro- scopical and molecular characterization. Schweizer Arch. Tierheilkunde. 2016, 158 (7), 529-532. https://doi.org/10.17236/sat00076
  15. Paul G., Kelly L., Snary E. Qualitative assessment for the release of sheep pox virus and lumpy skin disease virus into Great Britain from the European Union. AHVLA. February 2014, from https://www.gov.uk/government/.../qa-sheeppox-gb.pdf (accessed, December 2016).
  16. Bhanuprakash V., Venkatesan G., Balamurugan V., Hosamani M., Yogisharadhya R., Chauhan R. S., Pande A., Mondal B., Singh R. K. Pox outbreaks in Sheep and Goats at Makhdoom (Uttar Pradesh), India: Evidence of Sheeppox Virus Infection in Goats. Transbound. Emerg. Dis. 2010, N 57, P. 375–382. https://doi.org/10.1111/j.1865-1682.2010.01158.x
  17. OIE, Sheep Pox and Goat Pox in Greece. 2014, from http://www.oie.int/wahis_2/public/wahid.php/Reviewreport/Review?page_refer=MapFullEventReport&reportid=14914 (accessed, December 2016).
  18. Boshra H., Truong T., Nfon C., Gerdts V., Tikoo S., Babiuk L. A., Kara P., Mather A., Wallace.,  Babiuk S. Capripoxvirus-vectored vaccines against livestock diseases in Africa. Antivir. Res. 2013, N 98, P. 217–227.
  19. Diallo A., Viljoen G. J. Genus Capripoxvirus. Poxviruses. 2007, P. 167–181. doi: 10.1007/978-3-7643-7557-7_8. https://doi.org/10.1007/978-3-7643-7557-7_8
  20. Tian H., Chen Y., Wu J., Shang Y., Liu X. Serodiagnosis of sheeppox and goatpox using an indirect ELISA based on synthetic peptide targeting for the major antigen P32. Virol.  J. 2010, N 7, P. 245. doi: 10.1186/1743-422X-7-245. https://doi.org/10.1186/1743-422X-7-245
  21. Arda M. Fundamental Microbiology. Medisan Publising House. Ankara. 2006.
  22. Hendrix R. W., Casjens S. R. The Double Stranded DNA Viruses. Virus Taxonomy. 2005. Available at: http://dx.doi.org/10.1016/B978-0-12-249951-7.50010-9 (accessed, July, 2016). https://doi.org/10.1016/B978-0-12-249951-7.50010-9
  23. Haegeman A., Zro K., Sammin D., Vandenbussche F., Ennaji M. M., Clercq D. K. Investigation of a Possible Link Between Vaccination and the 2010 Sheep Pox Epizootic in Morocco. Transbound. Emerg. Dis. 2016, 63 (6), 278–287. https://doi.org/10.1111/tbed.12342
  24. Venkatesana G., Balamurugana V., Bhanuprakasha V. Multiplex PCR for simultaneous detection and differentiation of sheeppox, goatpox and orf viruses from clinical samples of sheep and goats. J. Virol. Meth. 2014, V. 195, P. 1–8. https://doi.org/10.1016/j.jviromet.2013.10.009
  25. Zro K., Azelmat S., Bendouro Y., Kuhn J. H., Fahime E. E., Ennaji M. M. PCR-based assay to detect sheeppox virus in ocular, nasal, and rectal swabs from infected Moroccan sheep. J. Virol.  Meth. 2014, N 204, P. 38–43. https://doi.org/10.1016/j.jviromet.2014.03.019
  26. Lamiena C. E., Lelenta M., Gogerb W., Silber R., Tuppurainend E., Matijevice M., Luckinsa A. G., Diallo A. Real time PCR method for simultaneous detection, quantitation and differentiation of capripoxviruses. J. Virol. Meth. 2011, N 171, P. 134–140. https://doi.org/10.1016/j.jviromet.2010.10.014
  27. Venkatesan G., Balamurugan V., Bhanuprakash V. TaqMan based real-time duplex PCR for simultaneous detection and quantitation of capripox and orf virus genomes in clinical samples. J. Virol. Meth. 2014, N 201, P. 44–50. https://doi.org/10.1016/j.jviromet.2014.02.007
  28. Venkatesan G., Balamurugan V., Bhanuprakash V., Singh R. K., Pandey A. B. Loop-mediated isothermal amplification assay for rapid and sensitive detection of sheep pox and goat pox viruses in clinical samples. Mol. Cell. Probes. 2016, V. 30, P. 174–177. https://doi.org/10.1016/j.mcp.2016.02.004
  29. Capstick P. B., Coackley W. Protection of cattle against lumpy skin disease I-Trials with a vaccine against Neethhng type infection. Res. Vet. Sci. 1961, N 2, P. 362–368.
  30. Davies F. G., Kitching R. P, Hammond J. M., Taylor W. P. In A single vaccine for the control of capripox refection m sheep and goats. Res. Vet. Sci. 1986, N 42, P. 53–60.
  31. Boumart Z., Daouam S., Belkourati I., Rafi L., Tuppurainen E., Tadlaoui K. O., Harrak M. E. Comparative innocuity and efficacy of live and inactivated sheeppox vaccines. BMC Vet. Res. 2016, V. 12, P. 133–139. https://doi.org/10.1186/s12917-016-0754-0
  32. Buyuktan?r O. Current Biotechnological Bacterial Vaccines. Atat?rk ?niversitesi Vet. Bil. Derg. 2010, 5 (2), 97–105.
  33. Akbuga J. Farmas?tik Biyoteknoloji ?r?nleri. M?SED. 2002, 3 (4), 54–62.
  34. Alt?nsoy N. A?? ?retim Teknikleri ve Kontrol?. A.?. Veteriner Fak?ltesi, Mikrobiyoloji, 2007. Available at: http://nihanaltinsoy.tr.gg/A%26%23351%3B%26%23305%3B--Ue-retim-Teknikleri-ve-Kontrol.ue.htm (accessed, September, 2016).
  35. Mayda G. DNA Vaccines. G?ncel Gastroentoroji. 1997, October, P. 406–411.
  36. Kuyucu N. Vaccines in Future. J. Klinik Geli?im. 2012, V. 25, P. 44–48.
  37. Karayel ?., Alkan F. DNA Vaccines and Their Using in Veterinary Medicine. Van Vet. J. 2015, 26 (3), 177–182.
  38. K?z?lbey K. Conjugation of melanoma based synthetic peptides with polyacrylic acid and their copolymers (Doctoral dissertation). Available from https://tez.yok.gov.tr/UlusalT ezMerkezi/.https://tez.yok.gov.tr/UlusalT ezMerkezi/. 2012. ( No. 312221).
  39. Chervyakova O. V., Zaitsev L. V., Iskakov B. K., Tailakova E. T., Strochkov V. M., Sultankulova K. T., Sandybayev N. T., Stanbekova G. E., Beisenov D. K., Abduraimov O. Y., Mambetaliyev M., Sansyzbay A. R., Kovalskaya N. Y., Nemchinov L. G., Hammond R. W. Recombinant Sheep Pox Virus Proteins Elicit Neutralizing Antibodies. Viruses. 2016, 8 (6), 159. https://doi.org/10.3390/v8060159
  40. Henderson L. M. Overview of marker vaccine and differential diagnostic test technology. Biologicals. 2005, V. 33, P. 203–209. https://doi.org/10.1016/j.biologicals.2005.08.006
  41. Liljeqvist S., Stahl S. Production of recombinant subunit vaccines: protein immunogens, live delivery systems and nucleic acid vaccines. J. Biotechnol. 1999, N 73, P. 1–33.  https://doi.org/10.1016/S0168-1656(99)00107-8
  42. Peptide Calculator. Available at: http://www.bachem.com/service-support/peptide-calculator/. (accessed,  February, 2017).
  43. Mustafaev M., Mustafaeva Z., Ergen E., Uraki Y., Sano Y. Novel betulin-containing polyelectrolyte Conjugates. J. Bioact. Compatible Polym. 2002, V. 17, P. 251–269. https://doi.org/10.1106/088391102027122
  44. Li W., Joshi D. M., Singhania S., Ramsey K. H., Murthy A. K. Peptide Vaccine: Progress and Challenges. Vaccines. 2014, N 2, P. 515–536. https://doi.org/10.3390/vaccines2030515
  45. Ozdemir Z. O., Karahan M., Karabulut E., Mustafaeva Z. Characterization of Foot-and-Mouth Disease Virus's Viral Peptides With LC-ESI-MS. J. Chem. Soc. Pak. 2010, 32 (4), 531–536.
  46. Basak I. E., Yasemin B. K., Zeynep M. A. Bioconjugation of Hepatitis B antigenic peptide with polymeric carriers through various carbodiimide chemistry. Turkish J. Biochem. 2011, N 36, P. 222–229.
  47. Moisa A. A., Kolesanova E. F. Synthetic Peptide Vaccines. Insight and Control of Infectious Disease in Global Scenario. P. K. Roy (Ed.). 2012, P. 201–228. doi: 10.5772/33496. https://doi.org/10.5772/33496
  48. Can F., Aray?c? P. P., Karahan A., Mustafaeva Z., Mamedov B. The Current Approaches  To Zika Virus Vaccination. Biotechnol. acta. 2016, 9 (4). https://doi.org/10.15407/biotech9.04.007
  49. Scorza F. B., Tsvetnitsky V., Donnelly J. J. Universal influenza vaccines: Shifting to better vaccines. Vaccine. 2016, 34 (16), 2926–2933. https://doi.org/10.1016/j.vaccine.2016.03.085
  50. 5Jakubke H., Sewald N. Peptides from A to Z:A Concise Encyclopedi. 2008. Weinheim, Wiley-Vch. https://doi.org/10.1002/9783527621187
  51. Yu H. M., Chen S. T., Wang K. T. Enhanced Coupling Efficiency in Solid-Phase Peptide Synthesis by Microwave Irradiation. J. Org. Chem. 1992, 57 (18), 4781–4788. https://doi.org/10.1021/jo00044a001
  52. Ozdemir Z. Developing bioconjugates which based on polyelectrolytes, using synthetic viral peptides (Doctoral dissertation). Available from https://tez.yok.gov.tr/UlusalTezMerkezi/. 2008. (No. 238986).
  53. Derman S., Mustafaeva A. Z., Abamor S. E., Ba??rova M., Allahverdiyev A. Preparation, characterization and immunological evaluation: canine parvovirus synthetic peptide loaded PLGA nanoparticles. J. Biomed. Sci. 2015, 22 (89). https://doi.org/10.1186/s12929-015-0195-2
  54. Mustafaev M. Functionally Biopolymer Systems. Sigma J. Engin. Nat. Sci. 2004, V. 4, P. 1–201.
  55. Mustafaev M. I. Biopolymers. T?B?TAK Marmara Research Center (MAM) Publishing House. 1996.
  56. Dilgimen A. S., Mustafaeva Z., Demchenko M., Kaneko T., Osada Y., Mustafaev M. Water-Soluble Covalent Conjugates of Bovine Serum Albumin With Anionic Poly(N-Isopropyl-Acrylamide) and Their Immunogenicity. Biomaterials. 2001, 22 (17), 2383–2392. https://doi.org/10.1016/S0142-9612(00)00425-7
  57. K?l?nc Y. B., Mustafaeva Z. M., Ko? R. ?., Ba??rova M., Allahverdiyev A. Synthesis and characterization of antigenic influenza A M2e protein peptide-poly(acrylic) acid bioconjugate and determination of toxicity in vitro. Bioengineered. 2014, 5 (6), 357–362. https://doi.org/10.4161/21655979.2014.969131
  58.  Topuzogullari M., Koc R. C., Isoglu S. D., Bagirova M., Mustafaeva Z. Conjugation, characterization and toxicity of lipophosphoglycan-polyacrylic acid conjugate for vaccination against leishmaniasis. J. Biomed. Sci. 2013. 20 (1), 35–43. https://doi.org/10.1186/1423-0127-20-35
  59.  Mansuro?lu B., Mustafaeva Z. Characterization of water-soluble conjugates of polyacrylic acid and antigenic peptide of FMDV by size exclusion chromatography with quadruple detection. Mat. Sci. Engin. 2012, 32 (2), 112–118. https://doi.org/10.1016/j.msec.2011.10.004
  60. Mustafaev M., Osada Y., Matsukata M., Basalp A., ?irakoglu B., Bermek E. New amphiphilic immunogens by Cu2+-mediated complexes of water-born poly(N-isopropylacrylamide) and bovine serum albumin. J. Biocat. Compet. Polym. 1998. V. 13, P. 33–49.
  61. Mustafaev M. I., Y?cel F., ?zt?rk S., ?irako?lu B., Bermek E. Immune response to progesterone involved in Cu 2+-mediated polyanion-protein complex—antigen specificity and affinity of hybridoma clones. J. Immunol. Lett. 1996, N 52, P. 63–68.
  62. Karahan M., Ozturkcan S. A., Mustafaeva. Z. Antitumor activity of polyelectrolytes-metal complexes. Roman. Biotechnol. Lett. 2013, 18 (4), 8447–8455.
  63. Karahan M., Mustafaeva Z., Ozeroglu C. The formation of polycomplexes of poly(methyl vinyl ether-CO-maleic anhydride) and bovine serum albumin in the presence of copper ions. Polish J. Chem. Technol. 2014, 16 (3), 97–105.  https://doi.org/10.2478/pjct-2014-0058
  64. Kadriye K., Serap D., Mustafaeva Z. Poly (N-vinyl-2-pyrrolidone-co-acrylic acid): Comparing of “Traditional Heating” and “Microwave-Assisted” Free Radical Polymerization. J. Chem. Soc. Pak. 2013, 35 (14), 1191–1196.
  65. Derman S., K?z?lbey K., Mansuro?lu B., Mustafaeva Z. Poly(N-Vinyl-2-Pyrrolidone-co-Acrylic Acid)-Bovine Serum Albumin Complex Formation Studied by HPLC and UV/Vis Spectroscopy. Roman. Biotechnol. Lett. 2011, 17 (4), 7408–7417.
  66. Mustafaeva Z. Polymers In Vaccine Formulation. Sigma J. Eng. Nat. Sci. 2016, 34 (3), 439–451.

{/accordions}